NCT04902872 2025-01-23Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCybrexa TherapeuticsPhase 1/2 Active not recruiting130 enrolled
NCT05199272 2024-11-15A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies23andMe, Inc.Phase 1/2 Active not recruiting141 enrolled
NCT05620134 2024-10-15Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics IncPhase 1/2 Active not recruiting263 enrolled